Metachondromatosis: genes and variants
Explore variant evidence for Metachondromatosis across 1 analyzed protein (PTPN11). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Metachondromatosis
PTPN11: Tyrosine-protein phosphatase non-receptor type 11
Its SHP2 phosphatase activity promotes RAS-MAPK signaling downstream of many receptor tyrosine kinases and cytokine receptors. Germline dysregulating variants cause Noonan-spectrum disorders, while somatic activating variants drive juvenile myelomonocytic leukemia and other cancers.
11 ClinVar pathogenic / likely pathogenic and 28 uncertain variants in PTPN11 have source records linked to Metachondromatosis. Association strength is not clinical gene validity.
Where Metachondromatosis variants cluster
- PTPN11 SH2 1 (positions 6–102): 7 of 11 ClinVar pathogenic / likely pathogenic variants, 3.9× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Metachondromatosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PTPN11 G60S | 60 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 G268S | 268 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 V428L | 428 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 E76D | 76 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 E69V | 69 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 A72G | 72 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 T73I | 73 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 P491T | 491 | Tyrosine-protein phosphatase | Pathogenic / likely pathogenic (★★) |
| PTPN11 N58K | 58 | SH2 1 | Pathogenic / likely pathogenic (★★) |
| PTPN11 T2I | 2 | Pathogenic / likely pathogenic (★★) | |
| PTPN11 F71L | 71 | SH2 1 | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Metachondromatosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 98 out of 100
- MutPred: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 86 out of 100
- CATVariant: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 84 out of 100
- MetaSVM: 69 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 63 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- RASopathy also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the Metachondromatosis variants (51 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the Metachondromatosis variants (44 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the Metachondromatosis variants (29 pathogenic / likely pathogenic).
- LEOPARD syndrome also has ClinVar records linked to PTPN11 variants; they fall mostly in different places as the Metachondromatosis variants (16 pathogenic / likely pathogenic).
- Monogenic short statue also has ClinVar records linked to PTPN11 variants; they fall partly in the same places as the Metachondromatosis variants (6 pathogenic / likely pathogenic).
Diseases related to Metachondromatosis
- RASopathy, also linked to PTPN11
- Noonan syndrome, also linked to PTPN11
- Noonan syndrome and Noonan-related syndrome, also linked to PTPN11
- Acute myeloid leukemia, also linked to PTPN11
- LEOPARD syndrome, also linked to PTPN11
- Heart disease, also linked to PTPN11
- Myelomonocytic leukemia, also linked to PTPN11
- Monogenic short statue, also linked to PTPN11
- Male infertility with azoospermia or oligozoospermia due to single gene mutation, also linked to PTPN11
- Microcephaly, also linked to PTPN11
- Non-immune hydrops fetalis, also linked to PTPN11
- Noonan syndrome with multiple lentigines, also linked to PTPN11
Frequently asked questions
Which genes have records linked to Metachondromatosis?
This view contains 1 analyzed proteins: PTPN11. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 54 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center